Observer variation in the diagnosis of superficial oesophageal adenocarcinoma
暂无分享,去创建一个
W H Henricks | J. Goldblum | T. Rice | A. Ormsby | L. Rybicki | J. Richter | R. Petras | W. Henricks | T W Rice | J R Goldblum | J E Richter | A H Ormsby | R E Petras | L A Rybicki
[1] M. Koike,et al. Histopathologic characteristics of early stage esophageal carcinoma: A comparative study with gastric carcinoma , 2010, Cancer.
[2] Patricia L. Blount,et al. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.
[3] Tarun Mullick. Telomerase upregulation in Barrett’s esophagus precedes the development of esophageal adenocarcinoma , 2001 .
[4] M F Dixon,et al. The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.
[5] C. Hsieh,et al. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study. , 1999, Zeitschrift fur Gastroenterologie.
[6] J. Goldblum,et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. , 1999, Gastrointestinal endoscopy.
[7] Edward L. Lee,et al. In situ hybridization for the detection of telomerase RNA in the progression from barrett's esophagus to esophageal adenocarcinoma , 1998, Cancer.
[8] E. Kuipers,et al. Epithelial Cell Proliferative Activity of Barrett's Esophagus (Methodology and Correlation with Traditional Cancer Risk Markers) , 1998, Digestive Diseases and Sciences.
[9] M. Younes,et al. p53 Protein Accumulation Is a Specific Marker of Malignant Potential in Barrett's Metaplasia , 1997, Digestive Diseases and Sciences.
[10] A. Cameron,et al. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. , 1997, The American journal of gastroenterology.
[11] C. Moskaluk,et al. p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. , 1996, Human pathology.
[12] R. Heitmiller,et al. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.
[13] A. Neugut,et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] J. Richardson,et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. , 1996, Annals of surgery.
[15] G. Tytgat,et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. , 1995, Surgical oncology.
[16] F. Bosman,et al. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus , 1995, The Journal of pathology.
[17] T. Rice,et al. Surgical management of high-grade dysplasia in Barrett's esophagus. , 1993, The American journal of gastroenterology.
[18] S. Li,et al. What is the Ideal Treatment for Early Esophageal Cancer? , 1993, Endoscopy.
[19] Patricia L. Blount,et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. , 1993, Gastroenterology.
[20] K. Sugimachi,et al. Long-term results of esophagectomy for early esophageal carcinoma. , 1993, Hepato-gastroenterology.
[21] W. Hop,et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. , 1992, Gut.
[22] P. Pairolero,et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? , 1992, The Annals of thoracic surgery.
[23] Douglas G. Altman,et al. Practical statistics for medical research , 1990 .
[24] B. Gayet,et al. Superficial Squamous Cell Carcinoma of the Esophagus: A Report of 76 Cases and Review of the Literature , 1989, The American journal of surgical pathology.
[25] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[26] R. R. Smith,et al. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.
[27] R. Lee. Dysplasia in Barrett's esophagus: A clinicopathologic study of six patients , 1985, The American journal of surgical pathology.
[28] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[29] D. Skinner,et al. Barrett's Esophagus: Comparison of Benign and Malignant Cases , 1983, Annals of surgery.
[30] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[31] D. Skinner,et al. Dysplasia in Barrett's esophagus , 2004, Journal of Cancer Research and Clinical Oncology.
[32] S. Semba,et al. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. , 1996, Journal of experimental therapeutics & oncology.
[33] N. Altorki,et al. High-grade dysplasia in the columnar-lined esophagus. , 1991, American journal of surgery.
[34] B. Reid,et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. , 1988, Gastroenterology.